Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue Suppl 2
06 Approved biologics for SLE: which to try first and in which patients? – The case for anifrolumab
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Lupus academy 12th annual meeting
Opening session (hybrid)
Hot topic: new era of treatments for SLE
06 Approved biologics for SLE: which to try first and in which patients? – The case for anifrolumab
Online download statistics by month:
Online download statistics by month: August 2023 to September 2024
Abstract
Full
Pdf
Aug 2023
20
0
3
Sep 2023
414
0
47
Oct 2023
134
0
25
Nov 2023
149
0
17
Dec 2023
158
0
13
Jan 2024
73
0
6
Feb 2024
231
0
15
Mar 2024
328
0
18
Apr 2024
337
0
15
May 2024
250
0
10
Jun 2024
260
0
10
Jul 2024
464
0
36
Aug 2024
209
0
11
Sep 2024
304
0
16
Total
3331
0
242
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF